FULL BODY TECH

The chart shows the growth of an initial investment of $10,000 in FULL BODY TECH, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

Based on dividend-adjusted daily data since Jul 27, 2018, FULL BODY TECH's average daily return is +0.10%, while the average monthly return is +1.84%. At this rate, your investment would double in approximately 3.2 years.

Historically, 65% of months were positive and 35% were negative. The best month was Nov 2022 with a return of +16.0%, while the worst month was Oct 2018 at -12.2%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 4 months.

On a daily basis, FULL BODY TECH closed higher 55% of trading days. The best single day was Apr 9, 2025 with a return of +10.6%, while the worst single day was Mar 16, 2020 at -11.4%.

FULL BODY TECH has an annualized alpha of 9.39%, beta of 1.18, and R² of 0.69 versus S&P 500 Index. Calculated based on daily prices since July 27, 2018.

• This portfolio captured 131.81% of S&P 500 Index gains but only 91.16% of its losses — a favorable profile for investors.
• This portfolio generated an annualized alpha of 9.39% versus S&P 500 Index — delivering returns beyond what market exposure alone would predict.

FULL BODY TECH has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

FULL BODY TECH ranks 10 for risk / return — in the bottom 10% of portfolios on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

FULL BODY TECH Sharpe ratios as of Apr 3, 2026 (values are recalculated daily):

• 1-Year: 0.45
• 5-Year: 0.46
• All Time: 0.80

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 0.98 to 1.66, this portfolio's current Sharpe ratio places it in the bottom 25%. This suggests weaker risk-adjusted returns than most portfolios, possibly due to lower returns, higher volatility, or both. It may be worth reviewing the allocation. You can use the Portfolio Optimization tool to explore options for improving the Sharpe ratio.

The chart below shows the rolling Sharpe ratio of FULL BODY TECH compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

FULL BODY TECH provided a 0.66% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the FULL BODY TECH. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the FULL BODY TECH was 35.16%, occurring on Nov 3, 2022. Recovery took 153 trading sessions.

The current FULL BODY TECH drawdown is 12.74%.

The chart below shows the rolling one-month volatility.